Nasdaq:US$14.48 (+0.07) | HKEX:HK$23.70 (+0.60) | AIM:£2.29 (+0.02)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 腫瘤學 / 免疫學 | 2007-05-23

Chi-Med completes patient enrolment on its HMPL-004 ulcerative colitis proof-of-concept; Phase II clinical trial in China